Article

Rheumatology Network's Top 5: March 26, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 26, 2021.

Rheumatoid Arthritis Quiz: RA Treat-to-Target

Treat-to-target is a key strategy used in the treatment of many chronic conditions. Test your knowledge of its use in rheumatoid arthritis.

Pregnancy Complications More Prevalent in Women With Axial Spondyloarthritis

“Understanding the impact of axSpA on pregnancy outcomes is a vital component of improving management of women with axSpA at every stage of their lives,” investigators stated.

Iberdomide Proven Effective in Treating Patients With SLE

Iberdomide, a high-affinity cereblon modulator, works by affecting leukocyte development and autoimmunity.

Acute Coronary Syndrome Rates Elevated in Patients With RA Receiving bDMARDs

Recent studies suggest that a gap in cardiovascular risk remains between patients with rheumatoid arthritis and the general population.

Childhood Rheumatic Disease Negatively Impacts Standardized Test Scores

Limited physical function, fatigue, mental health issues (resulting from chronic disease), and medication issues can further affect the ability of children with rheumatic disease from performing well in school.




Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
© 2024 MJH Life Sciences

All rights reserved.